Adeel Kaiser, MD
Education and Training
Dr. Kaiser received both his undergraduate and medical degrees from Johns Hopkins University. He completed his residency training at the University of California Irvine Integrated Program in Radiation Oncology, where he also served as Chief Resident. His training included over 1 year of clinical and research experience at the City of Hope National Cancer Center in southern California.
Following residency, Dr. Kaiser served as Assistant Professor at Loma Linda University Medical Center in Loma Linda, California. There he treated patients with breast, gastrointestinal and prostate malignancies using both photon and proton therapy techniques. Afterwards, he transitioned to Houston, Texas where he joined Northwest Radiation Oncology and served as the Medical Director of the Memorial Hermann Northeast Cancer Center.
In 2015, Dr. Kaiser joined the University of Maryland Department of Radiation Oncology faculty as Assistant Professor. He was named Associate Director of the Residency Program later that year.
Kaiser A, Mohiuddin MM, Jackson GL. Dramatic response from neoadjuvant, spatially fractionated GRID radiotherapy (SFGRT) for large, high-grade extremity sarcoma. Journal of Radiation Oncology. 2013;2(1):103-106.
Chabra A, Kaiser A, Regine WF, Chuong MD. The expanding role of stereotactic body radiation therapy for pancreatic cancer: a review of the literature. Translational Cancer Research. 2015;4(6):659-670.
Arpit Chhabra, Kimberly Marter, Quynh Le, Mark Mishra, Michael Chuong, Mohan Suntharalingam, and Adeel Kaiser. Carotid Artery Sparing with Photon and Proton based radiotherapy techniques for early stage glottic squamous cell carcinoma. Accepted for presentation at the upcoming 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting.
Dr. Kaiser’s primary research focus involves the development and clinical integration of metabolic therapy strategies for cancer patients. This holistic approach is intended to enhance the effectiveness of current treatments by taking advantage of the differences in the metabolisms of cancer cells and normal cells. In 2016, he was awarded a grant by the Mid-Atlantic Nutrition and Obesity Research Center to investigate the impact of dietary changes on patients with prostate cancer. Dr. Kaiser is also working to organize such complementary treatments into a defined therapeutic pathway called “The C.O.M.P.L.E.T.E Program,” or Comprehensive Oncologic Management of Patients by Linking Eating, Therapy and Exercise. The C.O.M.P.L.E.T.E. Program will aim at maximizing cancer treatment outcomes while also improving the overall well-being of patients. In addition to this research focus, Dr. Kaiser is also involved in a number of clinical trials utilizing proton therapy for a variety of different cancers.
Dr. Kaiser has authored numerous peer-reviewed publications, and received several awards of excellence including the American Brachytherapy Society Fellowship Award and the Roentgen Resident/Fellow Research Award by the Radiological Society of North America.
Dr. Kaiser has a breadth of experience treating all forms of adult cancers with techniques such as intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and proton therapy. He also treats hepatobiliary tumors with selective internal radiation therapy (SIRT) using radioactive microspheres. At this time he is accepting new patients with prostate, bladder, and gastrointestinal tumors for consultation at both the University of Maryland Medical Center and the Maryland Proton Treatment Center.